Su Suriguga

545 total citations
13 papers, 452 citations indexed

About

Su Suriguga is a scholar working on Hepatology, Molecular Biology and Epidemiology. According to data from OpenAlex, Su Suriguga has authored 13 papers receiving a total of 452 indexed citations (citations by other indexed papers that have themselves been cited), including 8 papers in Hepatology, 6 papers in Molecular Biology and 5 papers in Epidemiology. Recurrent topics in Su Suriguga's work include Liver physiology and pathology (6 papers), Liver Disease Diagnosis and Treatment (5 papers) and Liver Disease and Transplantation (3 papers). Su Suriguga is often cited by papers focused on Liver physiology and pathology (6 papers), Liver Disease Diagnosis and Treatment (5 papers) and Liver Disease and Transplantation (3 papers). Su Suriguga collaborates with scholars based in Netherlands, Thailand and China. Su Suriguga's co-authors include Peter Olinga, Henricus A. M. Mutsaers, Theerut Luangmonkong, Miriam Boersema, Geny M. M. Groothuis, Dorenda Oosterhuis, Koert P. de Jong, Chun-Hong Yu, Detlef Schuppan and Emilia Bigaeva and has published in prestigious journals such as Hepatology, British Journal of Pharmacology and Toxicology and Applied Pharmacology.

In The Last Decade

Su Suriguga

13 papers receiving 447 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Su Suriguga Netherlands 8 194 188 154 91 48 13 452
Theerut Luangmonkong Thailand 12 225 1.2× 235 1.3× 223 1.4× 98 1.1× 61 1.3× 17 643
Andrea S. Bedrosian United States 7 197 1.0× 197 1.0× 176 1.1× 160 1.8× 59 1.2× 8 774
Lukas Geisler Germany 9 144 0.7× 249 1.3× 216 1.4× 97 1.1× 35 0.7× 17 535
Chongyang Zhang China 6 289 1.5× 290 1.5× 141 0.9× 92 1.0× 38 0.8× 10 516
Kohji Otogawa Japan 7 148 0.8× 182 1.0× 128 0.8× 74 0.8× 35 0.7× 8 400
Nobuhito Taniki Japan 14 223 1.1× 286 1.5× 131 0.9× 62 0.7× 27 0.6× 43 589
Zoe Boyer‐Díaz Spain 7 218 1.1× 287 1.5× 109 0.7× 84 0.9× 35 0.7× 10 426
Maria Ruart Spain 7 189 1.0× 258 1.4× 124 0.8× 81 0.9× 39 0.8× 9 478
Ali Mencin United States 6 242 1.2× 340 1.8× 176 1.1× 117 1.3× 46 1.0× 7 670
Xiaodan Ren United States 11 204 1.1× 125 0.7× 103 0.7× 128 1.4× 38 0.8× 17 463

Countries citing papers authored by Su Suriguga

Since Specialization
Citations

This map shows the geographic impact of Su Suriguga's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Su Suriguga with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Su Suriguga more than expected).

Fields of papers citing papers by Su Suriguga

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Su Suriguga. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Su Suriguga. The network helps show where Su Suriguga may publish in the future.

Co-authorship network of co-authors of Su Suriguga

This figure shows the co-authorship network connecting the top 25 collaborators of Su Suriguga. A scholar is included among the top collaborators of Su Suriguga based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Su Suriguga. Su Suriguga is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

13 of 13 papers shown
1.
Suriguga, Su, Mei Li, Theerut Luangmonkong, et al.. (2022). Distinct responses between healthy and cirrhotic human livers upon lipopolysaccharide challenge: possible implications for acute-on-chronic liver failure. American Journal of Physiology-Gastrointestinal and Liver Physiology. 323(2). G114–G125. 5 indexed citations
2.
Iswandana, Raditya, Su Suriguga, Theerut Luangmonkong, et al.. (2020). Murine Precision-cut Intestinal Slices as a Potential Screening Tool for Antifibrotic Drugs. Inflammatory Bowel Diseases. 26(5). 678–686. 9 indexed citations
3.
Suriguga, Su, Theerut Luangmonkong, Henricus A. M. Mutsaers, Geny M. M. Groothuis, & Peter Olinga. (2020). Host microbiota dictates the proinflammatory impact of LPS in the murine liver. Toxicology in Vitro. 67. 104920–104920. 18 indexed citations
4.
Suriguga, Su. (2019). Pro- and anti-fibrotic agents in liver fibrosis: Perspective from an ex vivo model of liver fibrosis. Data Archiving and Networked Services (DANS). 1 indexed citations
5.
Luangmonkong, Theerut, Su Suriguga, Dorenda Oosterhuis, et al.. (2018). In vitro and ex vivo anti-fibrotic effects of LY2109761, a small molecule inhibitor against TGF-β. Toxicology and Applied Pharmacology. 355. 127–137. 14 indexed citations
6.
Luangmonkong, Theerut, Su Suriguga, Henricus A. M. Mutsaers, et al.. (2018). Targeting Oxidative Stress for the Treatment of Liver Fibrosis. Reviews of physiology, biochemistry and pharmacology. 175. 71–102. 219 indexed citations
7.
Jong, Iris E. M. de, A. Matton, Jasper B. van Praagh, et al.. (2018). Peribiliary Glands Are Key in Regeneration of the Human Biliary Epithelium After Severe Bile Duct Injury. Hepatology. 69(4). 1719–1734. 39 indexed citations
8.
Wei, Li, Zheng Guan, Jean‐Christophe Brisset, et al.. (2018). A nonalcoholic fatty liver disease cirrhosis model in gerbil: the dynamic relationship between hepatic lipid metabolism and cirrhosis.. PubMed. 11(1). 146–157. 4 indexed citations
9.
Yu, Chun-Hong, et al.. (2017). High glucose induced endothelial to mesenchymal transition in human umbilical vein endothelial cell. Experimental and Molecular Pathology. 102(3). 377–383. 57 indexed citations
10.
Luangmonkong, Theerut, Su Suriguga, Emilia Bigaeva, et al.. (2017). Evaluating the antifibrotic potency of galunisertib in a human ex vivo model of liver fibrosis. British Journal of Pharmacology. 174(18). 3107–3117. 72 indexed citations
11.
Suriguga, Su, Theerut Luangmonkong, Emilia Bigaeva, et al.. (2016). LPS aggravates fibrosis only in the early onset but not in the end stage of liver fibrosis. University of Groningen research database (University of Groningen / Centre for Information Technology). 64. 1 indexed citations
12.
Suriguga, Su, et al.. (2014). The role of ROS in hydroquinone-induced inhibition of K562 cell erythroid differentiation.. PubMed. 27(3). 212–4. 8 indexed citations
13.
Suriguga, Su, et al.. (2013). The role of catechol-O-methyltransferase in catechol-enhanced erythroid differentiation of K562 cells. Toxicology and Applied Pharmacology. 273(3). 635–643. 5 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Theerut Luangmonkong Breakdown of academic impact, for papers by Andrea S. Bedrosian Breakdown of academic impact, for papers by Lukas Geisler Breakdown of academic impact, for papers by Chongyang Zhang Breakdown of academic impact, for papers by Kohji Otogawa Breakdown of academic impact, for papers by Nobuhito Taniki Breakdown of academic impact, for papers by Zoe Boyer‐Díaz Breakdown of academic impact, for papers by Maria Ruart Breakdown of academic impact, for papers by Ali Mencin Breakdown of academic impact, for papers by Xiaodan Ren
Rankless by CCL
2026